Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations (Q37011738)

17 August 2017

1 reference

title

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations (English)

1 reference

17 August 2017

1 reference

2

Olufunmilayo I Olopade

1 reference

17 August 2017

James D Fackenthal

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

17 August 2017

published in

Nature Reviews Cancer

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

937-948

1 reference

Unusual case of Smith-Lemli-Opitz syndrome "type II"

17 August 2017

cites work

1 reference

Identification of the breast cancer susceptibility gene BRCA2

31 March 2020

1 reference

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

31 March 2020

1 reference

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

31 March 2020

1 reference

BRCA1 variants in a family study of African-American and Latina women

31 March 2020

1 reference

Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India

31 March 2020

1 reference

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

31 March 2020

1 reference

Polygenic Inherited Predisposition to Breast Cancer

31 March 2020

1 reference

How many more breast cancer predisposition genes are there?

31 March 2020

1 reference

A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques

31 March 2020

1 reference

Spectrum and prevalence ofBRCA1 andBRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening

31 March 2020

1 reference

A high proportion of founder BRCA1 mutations in Polish breast cancer families

31 March 2020

1 reference

Testing for BRCA1 mutations: a cost-effectiveness analysis

31 March 2020

1 reference

Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations

31 March 2020

1 reference

A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene

31 March 2020

1 reference

Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families

31 March 2020

1 reference

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

31 March 2020

1 reference

Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families

31 March 2020

1 reference

Large genomic deletions inactivate the BRCA2 gene in breast cancer families

31 March 2020

1 reference

Significant contribution of germline BRCA2 rearrangements in male breast cancer families

31 March 2020

1 reference

BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic

31 March 2020

1 reference

Novel germline BRCA1 and BRCA2 mutations in breast and breast/ovarian cancer families from the Czech Republic

31 March 2020

1 reference

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families

31 March 2020

1 reference

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry

31 March 2020

1 reference

Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families

31 March 2020

1 reference

Gene-Expression Profiles in Hereditary Breast Cancer

31 March 2020

1 reference

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

31 March 2020

1 reference

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

31 March 2020

1 reference

Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13

31 March 2020

1 reference

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

31 March 2020

1 reference

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

31 March 2020

1 reference

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

31 March 2020

1 reference

Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France

31 March 2020

1 reference

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

31 March 2020

1 reference

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

31 March 2020

1 reference

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

31 March 2020

1 reference

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

31 March 2020

1 reference

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

31 March 2020

1 reference

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

31 March 2020

1 reference

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing

31 March 2020

1 reference

Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up ofBRCA1Mutation Carriers

31 March 2020

1 reference

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

31 March 2020

1 reference

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

31 March 2020

1 reference

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

31 March 2020

1 reference

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study

31 March 2020

1 reference

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

31 March 2020

1 reference

A faux 3'-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay

31 March 2020

1 reference

Communication of the position of exon-exon junctions to the mRNA surveillance machinery by the protein RNPS1

31 March 2020

1 reference

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects

31 March 2020

1 reference

Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?

31 March 2020

1 reference

The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons

31 March 2020

1 reference

Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family

31 March 2020

1 reference

The founder effect and deleterious genes

31 March 2020

1 reference

MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population

31 March 2020

1 reference

The matrilineal ancestry of Ashkenazi Jewry: portrait of a recent founder event

31 March 2020

1 reference

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

31 March 2020

1 reference

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

31 March 2020

1 reference

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

31 March 2020

1 reference

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

31 March 2020

1 reference

Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients

31 March 2020

1 reference

Mutational analyses ofBRCA1 andBRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer

31 March 2020

1 reference

Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families

31 March 2020

1 reference

Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

31 March 2020

1 reference

The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim

31 March 2020

1 reference

mtDNA and the origin of the Icelanders: deciphering signals of recent population history

31 March 2020

1 reference

BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study

31 March 2020

1 reference

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

31 March 2020

1 reference

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

31 March 2020

1 reference

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

31 March 2020

1 reference

Risk of Endometrial Carcinoma Associated with BRCA Mutation

31 March 2020

1 reference

An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women

31 March 2020

1 reference

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

31 March 2020

1 reference

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

31 March 2020

1 reference

Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women?

31 March 2020

1 reference

Trends in breast cancer by race and ethnicity

31 March 2020

1 reference

Mitochondrial DNA and human evolution

31 March 2020

1 reference

Human demographic history: refining the recent African origin model

31 March 2020

1 reference

Genetic traces of ancient demography

31 March 2020

1 reference

Reconstructing human origins in the genomic era

31 March 2020

1 reference

Haplotype trees and modern human origins.

31 March 2020

1 reference

Genetic structure in four West African population groups

31 March 2020

1 reference

Genetic analysis of African populations: human evolution and complex disease

31 March 2020

1 reference

The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data

31 March 2020

1 reference

Genetic structure of human populations

31 March 2020

1 reference

Estimating African American admixture proportions by use of population-specific alleles

31 March 2020

1 reference

Evidence for a BRCA1 founder mutation in families of West African ancestry

31 March 2020

1 reference

Breast cancer genetics in African Americans

31 March 2020

1 reference

Racial differences in genetic factors associated with breast cancer

31 March 2020

1 reference

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

31 March 2020

1 reference

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study

31 March 2020

1 reference

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

31 March 2020

1 reference

Molecular portraits of human breast tumours

31 March 2020

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

31 March 2020

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

31 March 2020

1 reference

BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy

31 March 2020

1 reference

BRCA1 dysfunction in sporadic basal-like breast cancer

31 March 2020

1 reference

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

31 March 2020

1 reference

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

31 March 2020

1 reference

Prevalence and Predictors ofBRCA1andBRCA2Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 Years

31 March 2020

1 reference

Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women

31 March 2020

1 reference

Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases

31 March 2020

1 reference

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer

31 March 2020

1 reference

Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core

31 March 2020

1 reference

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

31 March 2020

1 reference

The "portrait" of hereditary breast cancer

31 March 2020

1 reference

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study

31 March 2020

1 reference

Constraints for genetic association studies imposed by attributable fraction and familial risk

31 March 2020

1 reference

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

31 March 2020

1 reference

Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2

31 March 2020

1 reference

The BOADICEA model of genetic susceptibility to breast and ovarian cancer

31 March 2020

1 reference

Assessing BRCA carrier probabilities in extended families.

31 March 2020

1 reference

Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations

31 March 2020

1 reference

The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse Populations

31 March 2020

1 reference

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

31 March 2020

1 reference

Linkage disequilibrium mapping in isolated populations: the example of Finland revisited

31 March 2020

1 reference

Mutational analysis of theBRCA1 gene in 30 Czech ovarian cancer patients

31 March 2020

1 reference

Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation

31 March 2020

1 reference

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study

31 March 2020

1 reference

Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan

31 March 2020

1 reference

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden

31 March 2020

1 reference

BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases

31 March 2020

1 reference

BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing

31 March 2020

1 reference

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

31 March 2020

1 reference

BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer

31 March 2020

1 reference

31 March 2020

1 reference

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer

31 March 2020

1 reference

Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.

31 March 2020

1 reference

Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations

31 March 2020

1 reference

Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study.

31 March 2020

1 reference

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer

31 March 2020

1 reference

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases

31 March 2020

1 reference

Germline BRCA2 mutations in men with breast cancer

31 March 2020

1 reference

BRCA2 germline mutations in male breast cancer patients in the Polish population

31 March 2020

1 reference

BRCA2 germ-line mutations in Spanish male breast cancer patients

31 March 2020

1 reference

BRCA2 germline mutations in male breast cancer cases and breast cancer families

31 March 2020

1 reference

BRCA1 and BRCA2 mutations in women from Shanghai China

31 March 2020

1 reference

Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients

31 March 2020

1 reference

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

31 March 2020

1 reference

Breast cancer predisposing alleles in Poland

31 March 2020

1 reference

Frequency of BRCA1 mutation 5382insC in German breast cancer patients.

31 March 2020

1 reference

Three per cent of Norwegian Ovarian Cancers are caused by BRCA1 1675delA or 1135insA

31 March 2020

1 reference

Prevalence of BRCA1 founder mutations in western Poland

31 March 2020

1 reference

Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland

31 March 2020

1 reference

Hereditary ovarian cancer in Poland.

31 March 2020

1 reference

RNA analysis of eightBRCA1andBRCA2unclassified variants identified in breast/ovarian cancer families from Spain

31 March 2020

1 reference

The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation

31 March 2020

1 reference

A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer

31 March 2020

1 reference

BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer

31 March 2020

1 reference

Germline BRCA1 185delAG mutations in Jewish women with breast cancer

31 March 2020

1 reference

Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast Cancer

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC2054

1 reference

17 August 2017

1 reference